N. Raheja

Rational design of a topical androgen receptor antagonist for the suppression of sebum production with properties suitable for follicular delivery.

T. R. Johnson, V. Shanmugasundaram, D. Pocalyko, 2010, Journal of medicinal chemistry.

Development of potent non-carbohydrate imidazole-based small molecule selectin inhibitors with antiinflammatory activity.

D. Slee, W. Ripka, J. Yu, 2001, Journal of medicinal chemistry.

Identification of (R)-6-(1-(4-cyano-3-methylphenyl)-5-cyclopentyl-4,5-dihydro-1H-pyrazol-3-yl)-2-methoxynicotinic acid, a highly potent and selective nonsteroidal mineralocorticoid receptor antagonist.

P. Loria, D. Hepworth, M. J. Meyers, 2014, Journal of medicinal chemistry.

Discovery of a series of 2-(1H-pyrazol-1-yl)pyridines as ALK5 inhibitors with potential utility in the prevention of dermal scarring.

Mostofa A Hena, B. Finzel, R. Gilbertsen, 2012, Bioorganic & medicinal chemistry letters.

Crystal Structures of PRK1 in Complex with the Clinical Compounds Lestaurtinib and Tofacitinib Reveal Ligand Induced Conformational Changes

B. Cathers, M. Abbasian, B. Pagarigan, 2014, PloS one.

Pantolactams as androgen receptor antagonists for the topical suppression of sebum production.

Danielle E. Dettling, V. Shanmugasundaram, S. Barrett, 2011, Bioorganic & medicinal chemistry letters.

Identification of (R)-6-(1-(4-cyano-3-methylphenyl)-5-cyclopentyl-4,5-dihydro-1H-pyrazol-3-yl)-2-methoxynicotinic acid, a highly potent and selective nonsteroidal mineralocorticoid receptor antagonist.

P. Loria, D. Hepworth, A. Casimiro-Garcia, 2014, Journal of Medicinal Chemistry.